News

Filter

Current filters:

None

Popular Filters

8151 to 8175 of 8458 results

Bristol-Myers Squibb and Roche link to test Yervoy and vemurafenib for melanoma

03-06-2011

US drug major Bristol-Myers Squibb (NYSE: BMY) has joined forces with Swiss major Roche (SIX: ROG) to…

Bristol-Myers SquibbOncologyPharmaceuticalResearchRochevemurafenibYervoy

US FDA says use of ARBs for hypertension does not increase risk of cancer

03-06-2011

The US Food and Drug Administration stated yesterday that a group of drugs used to control high blood…

Cardio-vascularNorth AmericaPharmaceuticalRegulation

India’s Lupin inks deal with NeuClone to develop oncology biosimilars

03-06-2011

Indian drugmaker Lupin (LPON: BO) has entered a strategic licensing agreement with Sydney, Australia-…

Asia-PacificBiotechnologyLicensingLupinNeuCloneOncologyResearch

Positive Ph III results for GSK and Theravance Relovair in COPD

03-06-2011

UK pharma giant GlaxoSmithKline (LSE: GSK) and development partner Theravance (Nasdaq: THRX) of the USA…

GlaxoSmithKlinePharmaceuticalRelovairResearchRespiratory and PulmonaryTheravance

Executive appointments at Almirall and Affymetrix

03-06-2011

Following the appointment of Eduardo Sanchiz as chief executive, Spain’s leading drugmaker, Almirall…

AffymetrixAlmirallManagementPharmaceutical

Misonix named exclusive US distributor of Anika’s Hyalomatrix skin substitute

03-06-2011

USA-based Anika Therapeutics (Nasdaq: ANIK), which specializes in products for tissue protection, healing,…

Anika TherapeuticsBiotechnologyHyalomatrixLicensingMisonix

FDA denies Citizen Petition on generic Combivir 180-day exclusivity “First Applicant” issue

03-06-2011

Last week, in a seven-page response, the US Food and Drug Administration denied an October 18, 2010 Citizen…

CombivirGenericsLegalLupinNorth AmericaPatentsTeva Pharmaceutical Industries

Investment in oncology drug development remains strong, with 133 firm initiating late-stage trials

03-06-2011

Trials targeting non-small cell lung cancer, breast cancer and multiple hematological cancers are amongst…

Boehringer IngelheimMerck KGaANovartisOncologyPharmaceuticalResearchRoche

CROMA and B&L’s eye drug Yellox approved by the European Commission

03-06-2011

Austria-based CROMA Pharma GmbH, a private global specialty pharmaceutical and surgical company, and…

Bausch & LombCROMA PharmaEuropeOphthalmicsPharmaceuticalRegulationYellox

Pfizer files for EU approval of axitinib in advanced kidney cancer

02-06-2011

The European Medicines Agency (EMA) has accepted US drugs behemoth Pfizer’s (NYSE: PFE) filing for…

axitinibEuropeOncologyPfizerPharmaceuticalRegulation

European Medicines Agency and HMA propose measures on dossier transparency

02-06-2011

A guidance document on the identification of commercially confidential information and protection of…

EuropePharmaceuticalRegulationResearch

Grifols must divest assets to complete acquisition of Talecris, says USA’s FTC

02-06-2011

The USA’s Federal Trade Commission will require Spanish firm Grifols (GRLS: MC), a manufacturer…

GrifolsMergers & AcquisitionsPharmaceuticalTalecris

D-Pharm in deal with China’s Jiangsu NHWA for epilepsy drug DP-VPA

02-06-2011

Israel-based clinical-stage biopharma company D-Pharm (TASE: DPRM) has entered into a licensing and co-development…

Asia-PacificD-PharmJiangsu NHWALicensingNeurologicalPharmaceutical

Tianyin granted production license for diabetes drug Gliclazide by China's SFDA

02-06-2011

Tianyin Pharmaceutical (NYSE Amex: TPI), a China-based pharmaceutical company that specializes in patented…

Asia-PacificDiabetesGliclazidePharmaceuticalRegulationTianyin Pharma

Progress Report 2011: Health care renewal in Canada

02-06-2011

A new report on Canada's health care performance, released this week by the Health Council of Canada,…

HealthcareNorth AmericaPharmaceutical

European Commission to lift suspension of Octapharma MA for Octagam

01-06-2011

The European Commission has adopted the European Medicines Agency’s recommendation 2011 to lift…

EuropeOctagamOctapharmaPharmaceuticalRare diseasesRegulation

Decrease in clinical trials in Finland continued into 2010

01-06-2011

These days, the number of clinical trials performed in Finland at the order of the pharmaceutical industry…

EuropeResearch

Positive Ph III results from Sanofi GetGoal Program on Lyxumia

01-06-2011

French drug major Sanofi (Euronext: SAN) announced today that new results from a Phase III study showed…

DiabeteslixisenatideLyxumiaPharmaceuticalResearchSanofiZealand Pharma

CBO Director reviews potential effects of a ban on DTC advertising of new Rx drugs in USA

01-06-2011

Direct-to-consumer (DTC) advertising of prescription drugs in the USA has elicited various concerns,…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

8151 to 8175 of 8458 results

Company Spotlight

Fibrotech

Fibrotech

Back to top